References

1. Lazarou J, Pomeranz B, Corey D et al. Incidence of adverse drug reactions in hospitalized patients: a metaanalysis of prospective studies. JAMA 1998;279:1200-5.

2. Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions. A systematic review. JAMA 2001;286: 2270-9.

3. Knowles SR, Uetrecht J, Shear NH. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet 2000;356:1587-91.

4. Meyer UA. Pharmacogenetics and adverse drug reactions. Lancet 2000;356:1667-71.

5. Eypasch E, Lefering R, Kum CK, Troidl H. Probability of adverse events that have not yet occurred: a statistical reminder. BMJ 1995;311:619-20.

6. Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 1983;249:1743-5.

7. Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions: current perspectives and future trends. JAMA 1999;281:824-9.

8. Venning GR. Identification of adverse reactions to new drugs. II. How were 18 important adverse reactions discovered and with what delays? BMJ 1983;286: 289-92;365-8.

9. Gruchalla RS. Clinical assessment of drug-induced disease. Lancet 2000;356:1505-11.

10. Edwards R, Lindquist M, Wiholm BE et al. Quality criteria for early signals of possible adverse drug reactions. Lancet 1990;336:156-8.

11. Meyboom RHB, Egherts ACG, Edwards JR et al. Principles of signal detection in pharmacovigilance. Drug Saf 1997;16:355-65.

12. Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood SM. Attitudinal survey of adverse reaction reporting by medical practitioners in the United Kingdom. Br J Pharmacol 1995;39:223-6.

13. Kaufman DW, Shapiro S. Epidemiological assessment of drug-induced disease. Lancet 2000;356:1339-43.

14. Van der Linden PD, van der Lei J, Vlug AE, Stricker BH. Skin reactions to antibacterial agents in general practice. J Clin Epidemiol 1998;51:703-8.

15. Fellay J, Boubaker K, Ledergerber B et al. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet 2001;358:1322-7.

16. Roujeau JC, Kelly JP, Naldi L et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.

17. Kelly JP, Auqier A, Rzany B et al. An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods. J Clin Epidemiol 1995;48:1099-108.

18. Roujeau JC, Guillaume JC, Fabre JP, Penso D, Flechet ML, Girre JP. Toxic epidermal necrolysis (Lyell's syndrome): incidence and drug etiology in France 1981-1985. Arch Dermatol 1990;126:37-42.

19. Schöpf E, Stühmer A, Rzany B, Victor N, Zentgraf R, Kapp JF. Toxic epidermal necrolysis and Stevens-Johnson syndrome: an epidemiologic study from West Germany. Arch Dermatol 1991;127:839-42.

20. Kaufman DW, Rosenberg L, Mitchell AA. Signal generation and clarification: use of case-control data. Pharmacoepidemiol Drug Saf 2001; 10:197-203.

21. Levine M, Walter S, Lee H, et al. Users' guides to the medical literature. IV. How to use an article about harm. JAMA 1994;271:1615-19.

22. Maistrello M, Morgutti M, Rossignoli A, Posca M. A selective guide to pharmacovigilance resources on the internet. Pharmacoepidemiol Drug Saf 1998;7:183-8.

23. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001;137:765-70.

24. Temple R. Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance. JAMA 1999;281:841-4.

25. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1998;318:1728-33.

26. Altman DG. Confidence intervals for the number needed to treat. BMJ 1998;317:1309-12.

27. Bjerre LM, LeLorier J. Expressing the magnitude of adverse effects in case-control studies: "the number of patients needed to treat for one additional patient to be harmed". BMJ 2000;320:503-6.

How To Reduce Acne Scarring

How To Reduce Acne Scarring

Acne is a name that is famous in its own right, but for all of the wrong reasons. Most teenagers know, and dread, the very word, as it so prevalently wrecks havoc on their faces throughout their adolescent years.

Get My Free Ebook


Post a comment